Practical Bayesian Guidelines for Phase IIB Clinical Trials (Q4842831): Difference between revisions

From MaRDI portal
RedirectionBot (talk | contribs)
Removed claim: author (P16): Item:Q1420349
Created claim: Wikidata QID (P12): Q52376624, #quickstatements; #temporary_batch_1711094041063
 
(3 intermediate revisions by 3 users not shown)
Property / author
 
Property / author: Richard M. Simon / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.2307/2533377 / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2007648830 / rank
 
Normal rank
Property / Wikidata QID
 
Property / Wikidata QID: Q52376624 / rank
 
Normal rank

Latest revision as of 15:17, 22 March 2024

scientific article; zbMATH DE number 786310
Language Label Description Also known as
English
Practical Bayesian Guidelines for Phase IIB Clinical Trials
scientific article; zbMATH DE number 786310

    Statements

    Practical Bayesian Guidelines for Phase IIB Clinical Trials (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    3 October 1995
    0 references
    0 references
    0 references
    0 references
    0 references
    sample size
    0 references
    phase IIB clinical trial
    0 references
    informative prior
    0 references
    decision boundaries
    0 references
    operating characteristics
    0 references
    0 references
    0 references